Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling.
暂无分享,去创建一个
Maurice P H M Jansen | Maxime P Look | J. Foekens | J. Klijn | A. Sieuwerts | M. Look | E. Berns | L. Dorssers | I. L. van Staveren | M. Jansen | H. Portengen | M. M. Meijer-van Gelder | M. M. Dirkzwager-Kiel | Kirsten Ritstier | Anieta M Sieuwerts | Henk Portengen | Jan G M Klijn | John A Foekens | Marion E Meijer-van Gelder | Iris L van Staveren | Els M J J Berns | Maaike M Dirkzwager-Kiel | Kirsten Ritstier | Lambert C J Dorssers
[1] Norman Wolmark,et al. Multi-gene Rt-pcr assay for predicting recurrence in node negative breast cancer patients-nsabp studies B-20 and B-14 , 2003 .
[2] M. Ringnér,et al. Impact of DNA amplification on gene expression patterns in breast cancer. , 2002, Cancer research.
[3] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[4] S. Mandlekar,et al. Mechanisms of tamoxifen-induced apoptosis , 2001, Apoptosis.
[5] Syed Mohsin,et al. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer , 2003, The Lancet.
[6] V. Jordan,et al. Tamoxifen: a most unlikely pioneering medicine , 2003, Nature Reviews Drug Discovery.
[7] C. Cropp,et al. Candidate target genes for loss of heterozygosity on human chromosome 17q21 , 2004, British Journal of Cancer.
[8] C. Iacobuzio-Donahue,et al. The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types. , 2002, Cancer research.
[9] R. Rubens,et al. Assessment of response to therapy in advanced breast cancer. A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland , 1977, European journal of cancer.
[10] Yudong D. He,et al. A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .
[11] Allison Jones,et al. cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells , 2003, Oncogene.
[12] C. McLaren,et al. Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients. , 2002, Gynecologic oncology.
[13] S. Ding,et al. Abnormality of the DNA double-strand-break checkpoint/repair genes, ATM, BRCA1 and TP53, in breast cancer is related to tumour grade , 2004, British Journal of Cancer.
[14] F. Spyratos,et al. Relationship between c-erbB-2 and other tumor characteristics in breast cancer prognosis. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[15] Annuska M Glas,et al. Gene expression profiles of primary breast tumors maintained in distant metastases , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[16] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[17] W. Carney,et al. Serum HER-2/neu and response to the aromatase inhibitor letrozole versus tamoxifen. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] Osborne Ck,et al. Tamoxifen in the Treatment of Breast Cancer , 1998 .
[19] Carsten O. Peterson,et al. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. , 2001, Cancer research.
[20] J. Foekens,et al. Aging of stromal-derived human breast fibroblasts might contribute to breast cancer progression , 2003, Thrombosis and Haemostasis.
[21] 佐治 重衡,et al. What's going on 乳癌 A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Ma XJ, Wang Z, Ryan PD, Isakoff SJ, Barmettler A, Fuller A, et al. Cancer Cell. 2004;5:607-16. PMID:15193263--術後補助療法におけるタモキシフェンへの反応性は2つの遺伝子レベルの測定によって予測しうることを示した論文 , 2005 .
[22] Wei Wang,et al. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. , 2004, Cancer cell.
[23] M. Macleod,et al. Effects of estrogen on global gene expression: identification of novel targets of estrogen action. , 2000, Cancer research.
[24] S. Dudoit,et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. , 2002, Nucleic acids research.
[25] B Angus,et al. Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer. , 1989, Cancer research.
[26] Alan Mackay,et al. Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer. , 2004, Cancer research.
[27] D. Hayes. Tamoxifen: Dr. Jekyll and Mr. Hyde? , 2004, Journal of the National Cancer Institute.
[28] E. Dougherty,et al. Gene-expression profiles in hereditary breast cancer. , 2001, The New England journal of medicine.
[29] T. H. van der Kwast,et al. High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer. , 2001, Cancer research.
[30] Barry Komm,et al. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. , 2003, Endocrinology.
[31] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[32] J. Stec,et al. Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[33] R. Osborne,et al. A genome-wide map showing common regions of loss of heterozygosity/allelic imbalance in breast cancer. , 2000, Cancer research.
[34] Vladimir B. Bajic,et al. ERGDB: Estrogen Responsive Genes Database , 2004, Nucleic Acids Res..